SEC Form 3 · accession 0000899243-18-018993
MusclePharm Corp · MSLP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Mark Blundell
10% Owner
Robert P Mahoney
10% Owner
Todd M. Enright
10% Owner
Donald Feagan
10% Owner
Period of report
Jun 22, 2018
Accepted (ET)
Jul 2, 2018 · 5:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001415684
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share | holding | — | — | — | 2,927,677 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
White Winston Select Asset Funds, LLC is an indirect beneficial owner of 2,927,677 shares of Issuer's Common Stock, par value $0.001 per share, by virtue of being a member and the sole manager of White Winston Select Asset Fund Series Fund MP-18, LLC. Messrs. Feagan, Blundell, Mahoney and Enright are indirect beneficial owners of 2,927,677 shares of Issuer's Common Stock, par value $0.001 per share, by virtue of being members and managers of White Winston Select Asset Funds, LLC, which is a member and the sole manager of White Winston Select Asset Fund Series Fund MP-18, LLC.